Sonoma Pharmaceuticals (SNOA) Liabilities from Discontinued Operations (2016 - 2020)
Sonoma Pharmaceuticals (SNOA) posted quarterly Liabilities from Discontinued Operations of 646000.0 for Q1 2020, up 476.79% quarter-over-quarter from 112000.0 in Q1 2016.
Sonoma Pharmaceuticals (SNOA) Liabilities from Discontinued Operations (2016 - 2020) Analysis & Trends
Sonoma Pharmaceuticals' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 646000.0 for Q1 2020.
- In Q1 2020, Liabilities from Discontinued Operations changed N/A year-over-year to 646000.0; the TTM figure through Mar 2020 stood at 646000.0 (changed N/A YoY), while the FY2020 annual figure was 646000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q1 2020 stood at 646000.0, up from 112000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 646000.0 in Q1 2020, with the low at 112000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 646,000.00 |
| Mar 31, 2020 | 646,000.00 |
| Mar 31, 2016 | 112,000.00 |
| Mar 31, 2016 | 112,000.00 |